MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/13872877251375430

Медицинская библиотека · Journal of Alzheimer's disease : JAD · 2025

A real-world study on the safety and efficacy of therapeutic plasma exchange in patients with Alzheimer's disease.

Taragano Fernando, Seinhart Daniel, Epstein Patricia, Sylvestre Vanina, Barañano Cecilia, Otero Castro Victoria, Sánchez Viviana, Kilstein Ariadna, González Ruben, Franco-Trecu Valentina, Costa-Urrutia Paula

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BackgroundTherapeutic plasma exchange (TPE) with albumin replacement has emerged as a potential treatment for Alzheimer's disease (AD). The AMBAR trial showed that TPE could slow cognitive and functional decline, along with changes in core and inflammatory biomarkers in cerebrospinal fluid.ObjectiveTo evaluate the safety and effectiveness of TPE in a real-world setting in Argentina.MethodsFrom 2022 to 2024, 32 patients with mild-to-moderate AD received TPE and were compared to a historical control group (2008-2018, n = 194) matched for inclusion criteria and cognitive assessments. The protocol included six weekly intensive sessions followed by at least 10 monthly maintenance sessions. Outcomes were measured using the Mini-Mental State Examination (MMSE), and tests of memory, language, executive function, and attention. Linear models were used for analysis.ResultsPatients had a mean age of 72.1 years; 42.4% were female. Baseline MMSE scores ranged from 15 to 26. A total of 514 procedures were performed; 81.5% were uneventful. Mild-to-moderate adverse events occurred in 18.5% of sessions, mainly related to venipuncture; no severe events were reported. Mean plasma exchange volumes were 88.2% and 49.8% of estimated plasma volume during the intensive and maintenance phases, respectively. TPE significantly slowed MMSE decline (45% less than controls, p < 0.001) and reduced memory deterioration (88% less in immediate recall, p < 0.001; 74% in delayed recall, p = 0.04). Other domains were also better preserved.ConclusionsTPE appears to be a safe and effective intervention for slowing cognitive decline in AD, supporting the AMBAR findings.

Для цитирования: Taragano Fernando, Seinhart Daniel, Epstein Patricia, Sylvestre Vanina, Barañano Cecilia, Otero Castro Victoria, Sánchez Viviana, Kilstein Ariadna, González Ruben, Franco-Trecu Valentina, Costa-Urrutia Paula. A real-world study on the safety and efficacy of therapeutic plasma exchange in patients with Alzheimer's disease.. Journal of Alzheimer's disease : JAD. 2025. DOI: 10.1177/13872877251375430.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.